drugset / Trial / NCT04831047

The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Eyelid Position, Eye Redness, and Eye Appearance

NCT04831047

Phase 4 Completed 114 enrolled University of Miami
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of the research is to see if Upneeq ( oxymetazoline 0.1% ophthalmic solution) has an effect on eyelid position, eye redness, or patient-perceived appearance of the eyes.

Timeline

Start
2021-06-08
Primary completion
2022-04-01
Completion
2022-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxymetazoline Other / unclassified 0.1 % Topical

Indications